Showing results (111-120 of 149) with videos related to

Sort By:
Pageof 15
Transplant Immunology|May 31, 2021
The response-guided ATG treatment provides a survival benefit and KPS recovery for patients with steroid refractory acute GVHD: The Nagasaki Transplant Group ExperienceMachiko Fujioka, Hidehiro Itonaga, Takafumi Furumoto, et al.
Experimental Hematology|November 9, 2010
High expression of 67-kDa laminin receptor relates to the proliferation of leukemia cells and increases expression of GM-CSF receptorKoji Ando, Yasushi Miyazaki, Yasushi Sawayama, et al.
International Journal of Hematology|June 16, 2011
Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blastsShinya Tominaga-Sato, Hideki Tsushima, Koji Ando, et al.
International Journal of Hematology|June 27, 2020
Programmed death 1 ligand (PD-L1) in solid cancers after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Nagasaki Transplant GroupSachie Kasai, Hidehiro Itonaga, Daisuke Niino, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 22, 2013
Distinct clinical features of infectious complications in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis in the Nagasaki transplant groupHidehiro Itonaga, Jun Taguchi, Takuya Fukushima, et al.
International Journal of Hematology|October 21, 2020
Correction to: Programmed death 1 ligand (PD-L1) in solid cancers after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Nagasaki Transplant GroupSachie Kasai, Hidehiro Itonaga, Daisuke Niino, et al.
Blood|October 27, 2012
Treatment of relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: the Nagasaki Transplant Group experienceHidehiro Itonaga, Hideki Tsushima, Jun Taguchi, et al.
The Journal of Biological Chemistry|February 9, 2013
Mutations in the nucleolar phosphoprotein, nucleophosmin, promote the expression of the oncogenic transcription factor MEF/ELF4 in leukemia cells and potentiates transformationKoji Ando, Hideki Tsushima, Emi Matsuo, et al.
Hematological Oncology|January 11, 2020
Treatment with mogamulizumab or lenalidomide for relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: The Nagasaki transplant group experienceHikaru Sakamoto, Hidehiro Itonaga, Yasushi Sawayama, et al.
Blood|May 19, 2017
Prognostic index for chronic- and smoldering-type adult T-cell leukemia-lymphomaHiroo Katsuya, Mototsugu Shimokawa, Kenji Ishitsuka, et al.
Pageof 15